scispace - formally typeset
S

Soo-Hyun Kim

Researcher at Catholic University of Korea

Publications -  12
Citations -  347

Soo-Hyun Kim is an academic researcher from Catholic University of Korea. The author has contributed to research in topics: Metastasis & Breast cancer. The author has an hindex of 10, co-authored 12 publications receiving 286 citations. Previous affiliations of Soo-Hyun Kim include University of Melbourne & Peter MacCallum Cancer Centre.

Papers
More filters
Journal ArticleDOI

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice.

TL;DR: The advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies are discussed.
Journal ArticleDOI

[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo.

TL;DR: Results indicate that [10]-gingerol may be a safe and useful complementary therapy for the treatment of metastatic breast cancer and warrant further investigation of its efficacy, either alone or in combination with standard systemic therapies, in pre-clinical models of metastasis, in patients and in patients.
Journal ArticleDOI

Neurotrophic activity of DA-9801, a mixture extract of Dioscorea japonica Thunb. and Dioscorea nipponica Makino, in vitro.

TL;DR: The NGF agonistic activity of DA- 9801 and DA-9801E was demonstrated, which may contribute to their neuroprotective effect against diabetic peripheral neuropathy (DPN).
Journal ArticleDOI

Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.

TL;DR: It is concluded that tumour, rather than stromal, β3 expression is essential and is required early for efficient spontaneous breast cancer metastasis to bone and soft tissues, and it is proposed that β3 inhibitors may be more efficacious if used in a neoadjuvant setting,rather than after metastases are established.
Journal ArticleDOI

Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro.

TL;DR: The data suggest that compounds 11 and 33 may exert a significant anti-solid tumor activity via a mechanism other than CDK inhibition, different from that of 4c and 4l.